In an oncological context, high expression of B7-H3 has been reported in several cancer types, including melanoma, glioma, breast and ovarian cancer, hepatocellular, colorectal, pancreatic, and non-small cell lung carcinoma (NSCLC). Here, CD276 is linked to non-small cell lung carcinoma.